Natural killer cells attenuate cytomegalovirus-induced hearing loss in mice

Congenital cytomegalovirus (CMV) infection is the most common non-hereditary cause of sensorineural hearing loss (SNHL) yet the mechanisms of hearing loss remain obscure. Natural Killer (NK) cells play a critical role in regulating murine CMV infection via NK cell recognition of the Ly49H cell surface receptor of the viral-encoded m157 ligand expressed at the infected cell surface. This Ly49H NK receptor/m157 ligand interaction has been found to mediate host resistance to CMV in the spleen, and lung, but is much less effective in the liver, so it is not known if this interaction is important in the context of SNHL. Using a murine model for CMV-induced labyrinthitis, we have demonstrated that the Ly49H/m157 interaction mediates host resistance in the temporal bone. BALB/c mice, which lack functional Ly49H, inoculated with mCMV at post-natal day 3 developed profound hearing loss and significant outer hair cell loss by 28 days of life. In contrast, C57BL/6 mice, competent for the Ly49H/m157 interaction, had minimal hearing loss and attenuated outer hair cell loss with the same mCMV dose. Administration of Ly49H blocking antibody or inoculation with a mCMV viral strain deleted for the m157 gene rendered the previously resistant C57BL/6 mouse strain susceptible to hearing loss to a similar extent as the BALB/c mouse strain indicating a direct role of the Ly49H/m157 interaction in mCMV-dependent hearing loss. Additionally, NK cell recruitment to sites of infection was evident in the temporal bone of inoculated susceptible mouse strains. These results demonstrate participation of NK cells in protection from CMV-induced labyrinthitis and SNHL in mice.

[1]  L. Zeng,et al.  Cochlear Spiral Ganglion Neuron Apoptosis in Neonatal Mice with Murine Cytomegalovirus-Induced Sensorineural Hearing Loss. , 2016, Journal of the American Academy of Audiology.

[2]  Bijal A. Parikh,et al.  Dual Requirement of Cytokine and Activation Receptor Triggering for Cytotoxic Control of Murine Cytomegalovirus by NK Cells , 2015, PLoS pathogens.

[3]  Steve D. M. Brown,et al.  Distinct expression and function of whirlin isoforms in the inner ear and retina: an insight into pathogenesis of USH2D and DFNB31. , 2015, Human molecular genetics.

[4]  K. Omori,et al.  Restricted infection of murine cytomegalovirus (MCMV) in neonatal mice with MCMV-induced sensorineural hearing loss. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[5]  S. Jonjić,et al.  Murine CMV-Induced Hearing Loss Is Associated with Inner Ear Inflammation and Loss of Spiral Ganglia Neurons , 2015, PLoS pathogens.

[6]  J. Bale,et al.  A diagnostic paradigm including cytomegalovirus testing for idiopathic pediatric sensorineural hearing loss , 2014, The Laryngoscope.

[7]  N. Terrazzini,et al.  Cell-mediated immunity to human CMV infection: a brief overview , 2014, F1000prime reports.

[8]  F. Shi,et al.  Ischemic neurons recruit natural killer cells that accelerate brain infarction , 2014, Proceedings of the National Academy of Sciences.

[9]  A. Park,et al.  A Comparison of Different Murine Models for Cytomegalovirus‐Induced Sensorineural Hearing Loss , 2013, The Laryngoscope.

[10]  M. Schleiss,et al.  Cytomegalovirus-induced sensorineural hearing loss with persistent cochlear inflammation in neonatal mice , 2011, Journal of NeuroVirology.

[11]  A. Park,et al.  Development of cytomegalovirus-mediated sensorineural hearing loss in a Guinea pig model. , 2010, Archives of otolaryngology--head & neck surgery.

[12]  W. Yokoyama,et al.  Stability of Murine Cytomegalovirus Genome after In Vitro and In Vivo Passage , 2009, Journal of Virology.

[13]  B. Plougastel,et al.  Ly49h is necessary for genetic resistance to murine cytomegalovirus , 2008, Immunogenetics.

[14]  K. Toellner,et al.  Ly49H+ NK Cells Migrate to and Protect Splenic White Pulp Stroma from Murine Cytomegalovirus Infection1 , 2008, The Journal of Immunology.

[15]  S. Grosse,et al.  Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  E. Karltorp,et al.  Congenital CMV infection: Prevalence in newborns and the impact on hearing deficit , 2008, Scandinavian journal of infectious diseases.

[17]  P. Tomasec,et al.  The Human Cytomegalovirus MHC Class I Homolog UL18 Inhibits LIR-1+ but Activates LIR-1− NK Cells1 , 2007, The Journal of Immunology.

[18]  C. Morton,et al.  Newborn hearing screening--a silent revolution. , 2006, The New England journal of medicine.

[19]  J. McGee,et al.  Frequency- and level-dependent changes in auditory brainstem responses (ABRS) in developing mice. , 2006, The Journal of the Acoustical Society of America.

[20]  M. Nei,et al.  Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Jonjić,et al.  Gain of Virulence Caused by Loss of a Gene in Murine Cytomegalovirus , 2004, Journal of Virology.

[22]  J. Hanna,et al.  Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. , 2004, Blood.

[23]  Amanda Honeycutt,et al.  Economic Costs of Mental Retardation, Cerebral Palsy, Hearing Loss, and Vision Impairment: Using Survey Data to Study Disability: Results from the National Health Interview Survey on Disability , 2002 .

[24]  Y. Tsutsui,et al.  Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons. , 2002, The American journal of pathology.

[25]  D. Fremont,et al.  Recognition of a virus-encoded ligand by a natural killer cell activation receptor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Lanier,et al.  Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors , 2002, Science.

[27]  S. Boppana,et al.  Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? , 1999, The Journal of pediatrics.

[28]  S. Jonjić,et al.  Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection , 1998, The Journal of experimental medicine.

[29]  O. Mandelboim,et al.  The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells , 1997, Nature.

[30]  W. Britt,et al.  Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. , 1997, The Journal of pediatrics.

[31]  Pass Rf Immunization strategy for prevention of congenital cytomegalovirus infection. , 1996 .

[32]  R. Burton,et al.  The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. , 1992, Journal of immunology.

[33]  S. Jonjić,et al.  Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes , 1990, Journal of virology.

[34]  A. Scalzo,et al.  Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen , 1990, The Journal of experimental medicine.

[35]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[36]  B. Woda,et al.  Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice , 1984, Journal of virology.

[37]  Principles and Guidelines for Early Hearing Detection and Intervention Programs , 2019 .

[38]  A. Park,et al.  Comparative analysis of detection methods for congenital cytomegalovirus infection in a Guinea pig model. , 2013, JAMA otolaryngology-- head & neck surgery.

[39]  R. Lawrence,et al.  Vaccines for the 21st Century , 2000 .

[40]  R. Pass Immunization strategy for prevention of congenital cytomegalovirus infection. , 1996, Infectious agents and disease.